1. EP159/#428 Real-world experience and common adverse events when using combination lenvatinib and pembrolizumab for the treatment of recurrent uterine cancer. (4th December 2022) Authors: Zammarrelli, William; Espino, Kevin; Yeoshoua, Effi; Ehmann, Sarah; Rubinstein, Maria; Green, Angela; Makker, Vicky Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 3 Page Start: A111 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. EP214/#508 Outcomes and long-term follow-up by treatment type for patients with advanced-stage ovarian cancer managed at a tertiary cancer center. (4th December 2022) Authors: Ehmann, Sarah; Shay, Kelly; Zhou, Qin; Iasonos, Alexia; Sonoda, Yukio; Gardner, Ginger; Roche, Kara Long; Zammarrelli, William; O'Cearbhaill, Roisin; Zivanovic, Oliver; Chi, Dennis Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 3 Page Start: A135 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗